03
August
2022


Share on networks

The German company Merck has invested 14.5 million euros in its facilities in Mollet del Vallès (Barcelona). This large investment will meet increased demand for the company’s specific products in its Life Sciences sector, such as the production of some Covid-19 vaccines.

The expansion project is a further demonstration of the Merck Group’s commitment to its operations in Catalonia while reinforcing its commitment to international supply solutions at this site, as production from the new building will be exported around the world.

Miguel Fernández Alcalde, Managing Director of Merck in Spain, said: “In the last 4 years Merck has invested a total of 90 million euros in the Mollet del Vallès site and in the biotechnology plant in Tres Cantos (Madrid). This has had a clear impact on our production and export capacity from Spain. Specifically, around 99% of the production developed at the Mollet del Vallès site is exported to other countries”.

Share on networks

Related news

Barcelona as an epicenter of science and innovation

News

Barcelona as an epicenter of science and innovation with the creation of the Barcelona Science Innovation District

Cataluña atrae inversiones extranjeras por valor de 880 millones de euros en 2023

News

Catalonia attracts foreign investments worth 880 million euros in 2023

Mountpark expandeix la seva presència a Espanya adquirint terreny per a la construcció d'un centre logístic

News

Mountpark expands its presence in Spain by acquiring land for the construction of a logistics center

Talus Real Estate consolida la seva presència en la logística catalana

News

Talus Real Estate consolidates its presence in Catalan logistics with an acquisition of 47,000 square meters